Circulating	O
endothelial	B-Cell
cells	I-Cell
in	O
malignant	B-Cancer
disease	I-Cancer
.	O

Cancer	B-Cancer
is	O
a	O
disease	O
largely	O
dependent	O
on	O
neoangiogenesis	O
.	O

Cancer	B-Cancer
neoangiogenesis	O
is	O
often	O
disordered	O
and	O
abnormal	O
,	O
with	O
evidence	O
of	O
coexisting	O
vascular	B-Tissue
endothelial	I-Tissue
dysfunction	O
.	O

A	O
novel	O
method	O
of	O
assessing	O
vascular	B-Tissue
endothelial	I-Tissue
function	O
in	O
cancer	B-Cancer
is	O
via	O
the	O
quantification	O
of	O
circulating	B-Cell
endothelial	I-Cell
cells	I-Cell
(	O
CEC	B-Cell
)	O
.	O

Unusual	O
in	O
healthy	O
individuals	O
,	O
their	O
presence	O
in	O
elevated	O
numbers	O
often	O
indicates	O
substantial	O
vascular	B-Tissue
endothelial	I-Tissue
perturbation	O
.	O

Another	O
interesting	O
cell	B-Cell
type	O
is	O
the	O
endothelial	B-Cell
progenitor	I-Cell
cell	I-Cell
(	O
EPC	B-Cell
)	O
,	O
whose	O
numbers	O
increase	O
in	O
the	O
presence	O
of	O
vascular	B-Multi-tissue_structure
damage	O
.	O

Recent	O
research	O
suggests	O
that	O
EPCs	B-Cell
have	O
an	O
important	O
role	O
in	O
tumor	B-Cancer
vasculogenesis	O
.	O

Another	O
marker	O
being	O
investigated	O
in	O
the	O
context	O
of	O
vascular	B-Multi-tissue_structure
dysfunction	O
and	O
coagulopathy	O
is	O
the	O
endothelial	B-Cellular_component
microparticle	I-Cellular_component
(	O
EMP	B-Cellular_component
)	O
.	O

Thus	O
,	O
CECs	B-Cell
,	O
EPCs	B-Cell
and	O
EMPs	B-Cellular_component
may	O
represent	O
potentially	O
novel	O
methods	O
for	O
evaluating	O
the	O
vascular	B-Multi-tissue_structure
status	O
of	O
cancer	B-Cancer
patients	O
.	O

This	O
review	O
will	O
summarize	O
the	O
current	O
position	O
of	O
CECs	B-Cell
,	O
EPCs	B-Cell
and	O
EMPs	B-Cellular_component
in	O
cell	B-Cell
biology	O
terms	O
,	O
with	O
particular	O
emphasis	O
on	O
their	O
relationship	O
to	O
malignant	B-Cancer
disease	I-Cancer
.	O

